Skip to main content
. Author manuscript; available in PMC: 2023 Jul 1.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2022 Mar 29;113(3):542–551. doi: 10.1016/j.ijrobp.2022.03.007

Figure 1.

Figure 1.

Overall survival and disease-free survival by response to neoadjuvant therapy for patients enrolled on NSABP B-40 and B-41. (A) Overall survival for cN+ patients; (B) disease-free survival for cN+ patients; (C) overall survival for cN− patients; and (D) disease-free survival for cN− patients; aNbN = ypT+N+; aNbP = ypT0N+; aPbN= ypT+N0; aPbP = ypT0N0